Amendment #1 to Form 10-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-K/A

 

AMENDMENT NO. 1 TO

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Fiscal Year Ended: February 28, 2003

 

Commission File Number: 1-12777

 


 

AZZ incorporated

(Exact name of registrant as specified in its charter)

 

Texas   75-0948250
(State of incorporation)   (I.R.S. Employer Identification Number)

 

University Centre I, Suite 200

1300 South University Dr.

Fort Worth, Texas

 

76107

(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, including Area Code: (817) 810-0095

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Name of Exchange on Which Registered
Common Stock $1.00 par value   New York Stock Exchange

 

Securities registered pursuant to Section 12(g) of the Act: None


 


PART IV

 

Item 15. Exhibits, Financial Statement Schedules, and Reports on Form 8-K

 

C.   Exhibits Required by Item 601 of Regulation S-K

 

Exhibit No. 23, Consent of Ernst & Young, LLP filed with Form 10-K on May 27, 2003, is revised and is attached as Exhibit 23 to this Form 10-K/A.

 

 

1


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

       

AZZ incorporated

(Registrant)

DATE: 9/26/03       By:  

/s/ David H. Dingus


               

David H. Dingus

Principal Executive Officer and Director

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of Registrant and in the capacities and on the dates indicated.

 

/s/ David H. Dingus


David H. Dingus, Principal Executive

Officer and Director

     

/s/ Dana L. Perry


Dana L. Perry, Principal Accounting Officer,

Principal Financial Officer, and Director

 

Daniel E. Berce*


Daniel E. Berce, Director

     

Martin C. Bowen*


Martin C. Bowen, Director

 

Dr. H. Kirk Downey*


Dr. H. Kirk Downey, Chairman of the

Board and Director

     

Daniel R. Feehan*


Daniel R. Feehan, Director

 

 


Robert H. Johnson, Director

     

Kevern R. Joyce*


Kevern R. Joyce, Director

 

/s/ Sam Rosen


Sam Rosen, Director

     

R. J. Schumacher*


R. J. Schumacher, Director

 

 


W. C. Walker, Director

     

/s/ Dana L. Perry


Dana L. Perry, Attorney-in-Fact Under

Power of Attorney filed as Exhibit 24 to Form 10-K

 

 

2